On or around 03/04/2016 (Ongoing date of last review)
Filing Date: October 06, 2015
According to the Complaint, is it alleged that the consideration offered to Cytec’s public stockholders in the Proposed Transaction is unfair and inadequate because, among other things, the intrinsic value of Cytec’s common stock is materially in excess of the amount offered for those securities in the Proposed Transaction given the Company’s prospects for future growth and earnings and the value Solvay attributes to its future success based on the Merger.
Company & Securities Information
Defendant: Cytec Industries Inc.
Sector: Basic Materials
Industry: Chemical Manufacturing
Headquarters: United States
Ticker Symbol: CYT
Company Market: New York SE
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Keith M. Lagarde, et al. v. Cytec Industries Inc., et al.